Key Findings

The study identifies the blaIMP-3 gene, a variant of the IMP-1 metallo-beta-lactamase, which confers resistance to β-lactam antibiotics through specific amino acid substitutions. The mutation at nucleotide 640 (G→A) leads to a Ser→Gly substitution at position 196, enhancing resistance to ampicillin and ceftazidime.